Evidence map›Paper›PMID 29921669›Full record

ArticlemBio2018

CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.

Alline R Pacheco, Jacob E Lazarus, Brandon Sit, Stefanie Schmieder, Wayne I Lencer, Carlos J Blondel, John G Doench, Brigid M Davis, Matthew K Waldor

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  10. Recent Advances in CRISPR-Cas Technologies for Synthetic Biology.Journal of microbiology (Seoul, Korea) · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Role of Globotriaosylceramide in Physiology and Pathology.Frontiers in molecular biosciences · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Alline R PachecoDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jacob E LazarusDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Brandon SitDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Stefanie SchmiederDivision of Gastroenterology, Boston Children's Hospital, Boston, Massachusetts, USA.
Wayne I LencerDivision of Gastroenterology, Boston Children's Hospital, Boston, Massachusetts, USA.
Carlos J BlondelDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
John G DoenchBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Brigid M DavisDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Matthew K WaldorDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA mwaldor@research.bwh.harvard.edu.
Harvard University · USBoston Children's Hospital · USBrigham and Women's Hospital · USBroad Institute · US

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Vibrio cholerae intestinal colonization and vaccine developmentR01AI042347 · NIAID · TUFTS UNIVERSITY BOSTON · PI WALDOR, MATTHEW K · 1998 to 2025
$7.3M
Intestinal Disease-enterocyte toxin interactionR37DK048106 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI LENCER, WAYNE I · 2011 to 2020
$7.0M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI042347NIAID NIH HHS T32 AI007061NIDDK NIH HHS P30 DK034854NIDDK NIH HHS R37 DK048106
6 · The paper itself

Abstract

Enterohemorrhagic

Indexed as

Biosynthetic PathwaysCell LineCell SurvivalClustered Regularly Interspaced Short Palindromic RepeatsEnterohemorrhagic Escherichia coliEpithelial CellsEscherichia coli InfectionsGene TargetingGenetic LociGenome-Wide Association StudyHost-Pathogen InteractionsHumansMutationShiga ToxinSphingolipidsTrihexosylceramidesglobotriaosylceramideShiga ToxinSphingolipidsTrihexosylceramidesType III Secretion SystemsVirulence FactorsCRISPR screenEHECEPEChost susceptibilityLAPTM4AShiga toxinsphingolipid synthesisT3SSTM9SF2

Identifiers

PMID29921669
PMCPMC6016243
OpenAlexW2802556167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.